Clinical Trials Directory

Trials / Completed

CompletedNCT07375875

Strategies to Minimize the Risk for Insulin Induced Hypertrophy and Its Related Consequences

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
170 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Hypertrophy caused by insulin has effects that extend beyond just aesthetic concerns. Innovative methods have shown potential in decreasing the chances of hypertrophy and its related issues, including the development of detailed diagrams of insulin injection locations and tailored rotation plans. This study aimed to assess the impact of a novel insulin injection sites map (digital or physical) on the incidence of insulin-induced hypertrophy, adherence to rotation protocols, glycemic control, and patient experience among diabetes patients treated with insulin between study and control group along six months of follow up

Detailed description

Patients on long-term insulin therapy frequently experience significant side effect of insulin-induced hypertrophy, particularly lipohypertrophy (LH).Nurses play a crucial role as direct care providers and educators for diabetes patients, ensuring the safe administration of insulin and preventing insulin-related hypertrophy. This research aims to explore and evaluate innovative mapping methods for insulin injection locations due to the rising prevalence of diabetes in Egypt and the United States, alongside the considerable effect that insulin-induced hypertrophy has on patient results and healthcare systems

Conditions

Interventions

TypeNameDescription
PROCEDUREGroup(1) Insulin site injection mapThe intervention group participants attended a structured educational session focused on strategies to reduce the risk of insulin-induced hypertrophy and its associated consequences, either individually or in small groups . The session included: appropriate insulin injection techniques, since repeated trauma is the main cause of hypertrophy, the researchers explained "standardized rotation protocols and insulin injection sites map"

Timeline

Start date
2025-05-15
Primary completion
2025-12-15
Completion
2025-12-15
First posted
2026-01-29
Last updated
2026-01-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07375875. Inclusion in this directory is not an endorsement.